Cargando…

2955. The Impact of the Healthcare Environment on the Nasal Microbiome in Children with Cancer

BACKGROUND: Children with cancer are at risk for healthcare associated infections (HAIs) given their immunosuppression as well as frequent hospitalizations and antibiotic and antiseptic exposure. The degree to which the healthcare environment impacts the flora of children with cancer and its subsequ...

Descripción completa

Detalles Bibliográficos
Autores principales: McNeil, Jonathon C, Sommer, Lauren M, Joseph, Marritta, Runge, Jessica, Murugesan, Marudhu, Brackett, Julienne, Mitchell, Amya, Wilber, Matthew, Ann Luna, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676916/
http://dx.doi.org/10.1093/ofid/ofad500.194
_version_ 1785150006798319616
author McNeil, Jonathon C
Sommer, Lauren M
Joseph, Marritta
Runge, Jessica
Murugesan, Marudhu
Brackett, Julienne
Mitchell, Amya
Wilber, Matthew
Ann Luna, Ruth
author_facet McNeil, Jonathon C
Sommer, Lauren M
Joseph, Marritta
Runge, Jessica
Murugesan, Marudhu
Brackett, Julienne
Mitchell, Amya
Wilber, Matthew
Ann Luna, Ruth
author_sort McNeil, Jonathon C
collection PubMed
description BACKGROUND: Children with cancer are at risk for healthcare associated infections (HAIs) given their immunosuppression as well as frequent hospitalizations and antibiotic and antiseptic exposure. The degree to which the healthcare environment impacts the flora of children with cancer and its subsequent role in infection is uncertain. We prospectively evaluated the nasal microbiome in children with malignancy relative to healthy children. METHODS: Subjects were enrolled into two cohorts. The high risk cohort included children with a new diagnosis of malignancy recruited from the Texas Children’s Hospital Cancer Center. Children in the low risk cohort were otherwise healthy and enrolled from two Houston area general pediatrics clinics. Subjects had anterior nares swab samples obtained at 3-month intervals for one year. Genomic material was extracted from samples and the 16S rRNA V4 region was amplified and sequenced. Microbiome analysis was performed using QIIME 2, and comparisons in both bacterial diversity (alpha diversity via Shannon index) and composition (genus-level) were made based on cohort and time point. We present early data from the time of subject enrollment and first follow-up. RESULTS: 272 subjects were enrolled. Cohorts were similar in terms of demographics. No subjects were neutropenic at time of sample collection. High-risk subjects were significantly more likely to have received antibiotics (96.4% vs. 17.5%, p< 0.01) and/or chlorhexidine gluconate containing products (91.6% vs. 0%, p< 0.01) in the 90 days prior to enrollment. Within the high-risk cohort, 98.8% had received antineoplastic chemotherapy. Alpha diversity (Shannon index) was lower in the high risk cohort compared to the low risk cohort. In the high-risk cohort, the genera Staphylococcus and Corynebacterium were disproportionately represented relative to the low-risk cohort in which Moraxella predominated (Figure 1). Nasal microbiota were similar across cancer diagnoses. [Figure: see text] CONCLUSION: There are significant changes in the nasal microbiota of children with cancer relative to healthy children. These findings suggest a high impact of healthcare exposure and specifically antibiotics and antiseptics on colonizing flora. Further work is needed to understand how these microbiome perturbations modify risk for HAI. DISCLOSURES: Jonathon C. McNeil, MD, Allergan: Grant/Research Support|Nabriva Therapeutics: Grant/Research Support
format Online
Article
Text
id pubmed-10676916
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106769162023-11-27 2955. The Impact of the Healthcare Environment on the Nasal Microbiome in Children with Cancer McNeil, Jonathon C Sommer, Lauren M Joseph, Marritta Runge, Jessica Murugesan, Marudhu Brackett, Julienne Mitchell, Amya Wilber, Matthew Ann Luna, Ruth Open Forum Infect Dis Abstract BACKGROUND: Children with cancer are at risk for healthcare associated infections (HAIs) given their immunosuppression as well as frequent hospitalizations and antibiotic and antiseptic exposure. The degree to which the healthcare environment impacts the flora of children with cancer and its subsequent role in infection is uncertain. We prospectively evaluated the nasal microbiome in children with malignancy relative to healthy children. METHODS: Subjects were enrolled into two cohorts. The high risk cohort included children with a new diagnosis of malignancy recruited from the Texas Children’s Hospital Cancer Center. Children in the low risk cohort were otherwise healthy and enrolled from two Houston area general pediatrics clinics. Subjects had anterior nares swab samples obtained at 3-month intervals for one year. Genomic material was extracted from samples and the 16S rRNA V4 region was amplified and sequenced. Microbiome analysis was performed using QIIME 2, and comparisons in both bacterial diversity (alpha diversity via Shannon index) and composition (genus-level) were made based on cohort and time point. We present early data from the time of subject enrollment and first follow-up. RESULTS: 272 subjects were enrolled. Cohorts were similar in terms of demographics. No subjects were neutropenic at time of sample collection. High-risk subjects were significantly more likely to have received antibiotics (96.4% vs. 17.5%, p< 0.01) and/or chlorhexidine gluconate containing products (91.6% vs. 0%, p< 0.01) in the 90 days prior to enrollment. Within the high-risk cohort, 98.8% had received antineoplastic chemotherapy. Alpha diversity (Shannon index) was lower in the high risk cohort compared to the low risk cohort. In the high-risk cohort, the genera Staphylococcus and Corynebacterium were disproportionately represented relative to the low-risk cohort in which Moraxella predominated (Figure 1). Nasal microbiota were similar across cancer diagnoses. [Figure: see text] CONCLUSION: There are significant changes in the nasal microbiota of children with cancer relative to healthy children. These findings suggest a high impact of healthcare exposure and specifically antibiotics and antiseptics on colonizing flora. Further work is needed to understand how these microbiome perturbations modify risk for HAI. DISCLOSURES: Jonathon C. McNeil, MD, Allergan: Grant/Research Support|Nabriva Therapeutics: Grant/Research Support Oxford University Press 2023-11-27 /pmc/articles/PMC10676916/ http://dx.doi.org/10.1093/ofid/ofad500.194 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
McNeil, Jonathon C
Sommer, Lauren M
Joseph, Marritta
Runge, Jessica
Murugesan, Marudhu
Brackett, Julienne
Mitchell, Amya
Wilber, Matthew
Ann Luna, Ruth
2955. The Impact of the Healthcare Environment on the Nasal Microbiome in Children with Cancer
title 2955. The Impact of the Healthcare Environment on the Nasal Microbiome in Children with Cancer
title_full 2955. The Impact of the Healthcare Environment on the Nasal Microbiome in Children with Cancer
title_fullStr 2955. The Impact of the Healthcare Environment on the Nasal Microbiome in Children with Cancer
title_full_unstemmed 2955. The Impact of the Healthcare Environment on the Nasal Microbiome in Children with Cancer
title_short 2955. The Impact of the Healthcare Environment on the Nasal Microbiome in Children with Cancer
title_sort 2955. the impact of the healthcare environment on the nasal microbiome in children with cancer
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676916/
http://dx.doi.org/10.1093/ofid/ofad500.194
work_keys_str_mv AT mcneiljonathonc 2955theimpactofthehealthcareenvironmentonthenasalmicrobiomeinchildrenwithcancer
AT sommerlaurenm 2955theimpactofthehealthcareenvironmentonthenasalmicrobiomeinchildrenwithcancer
AT josephmarritta 2955theimpactofthehealthcareenvironmentonthenasalmicrobiomeinchildrenwithcancer
AT rungejessica 2955theimpactofthehealthcareenvironmentonthenasalmicrobiomeinchildrenwithcancer
AT murugesanmarudhu 2955theimpactofthehealthcareenvironmentonthenasalmicrobiomeinchildrenwithcancer
AT brackettjulienne 2955theimpactofthehealthcareenvironmentonthenasalmicrobiomeinchildrenwithcancer
AT mitchellamya 2955theimpactofthehealthcareenvironmentonthenasalmicrobiomeinchildrenwithcancer
AT wilbermatthew 2955theimpactofthehealthcareenvironmentonthenasalmicrobiomeinchildrenwithcancer
AT annlunaruth 2955theimpactofthehealthcareenvironmentonthenasalmicrobiomeinchildrenwithcancer